Medtronic shareholders OK $48 billion Covidien acquisition

SHARE Medtronic shareholders OK $48 billion Covidien acquisition

MINNEAPOLIS — Medtronic shareholders have approved the acquisition the surgical supplier Covidien in a corporate deal valued at about $48 billion.

Some shareholders were angered by the acquisition of Covidien because it moves the legal headquarters of the combined company to Ireland. Covidien is based in Dublin.

The owners of about 75 percent of Medtronic’s outstanding shares voted Tuesday in favor of the deal, which is the largest transaction in the history of the Minneapolis company.

The Star Tribune reports about 100 people attended the investors meeting at the Hyatt Regency in Minneapolis where Medtronic chief executive Omar Ishrak fielded emotionally charged questions.

The deal was also approved by Covidien shareholders Tuesday. It still needs approval from the Irish High Court.

Medtronic is paying $35.19 per share and exchanging each Covidien share for 0.956 shares in the new company.

The Latest
Despite getting into foul trouble, which limited him to just six minutes in the second half, Shannon finished with 29 points, five rebounds and two assists.
Cowboy hats, bell-bottoms and boots were on full display Thursday night as fans lined up for the first of his three sold-out shows.
The incident occurred about 3:40 p.m. near Minooka. The horse was successfully placed back into the trailer, and the highway reopened about 40 minutes later. No injuries were reported.
The Hawks conceded the game’s only two goals within the first seven minutes and were shut out for the 12th time this season in a 2-0 defeat Thursday.